IBSA Institut Biochimique v. Teva Pharmaceuticals USA
IBSA INSTITUT BIOCHIMIQUE, S.A., IBSA PHARMA INC. and ALTERGON, S.A. |
TEVA PHARMACEUTICALS USA, INC. |
19-2400 |
September 16, 2019 |
U.S. Court of Appeals, Federal Circuit |
Other |
Opinions
We have the following opinions for this case:
Description |
---|
IBSA Institut Biochimique v. Teva Pharmaceuticals USA |
Docket Report
This docket was last retrieved on September 30, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 15 Entry of appearance for Ryan P. Johnson as of counsel for Appellants Altergon, S.A., IBSA Institut Biochimique, S.A. and IBSA Pharma Inc.. Service: 09/30/2019 by email. [639201] [19-2400] [Ryan Johnson] [Entered: 09/30/2019 04:56 PM] |
Filing 14 Entry of appearance for Erica R. Sutter as of counsel for Appellants Altergon, S.A., IBSA Institut Biochimique, S.A. and IBSA Pharma Inc.. Service: 09/30/2019 by email. [639199] [19-2400] [Erica Sutter] [Entered: 09/30/2019 04:52 PM] |
Filing 13 Entry of appearance for Laura T. Moran as of counsel for Appellants Altergon, S.A., IBSA Institut Biochimique, S.A. and IBSA Pharma Inc.. Service: 09/30/2019 by email. [639195] [19-2400] [Laura Moran] [Entered: 09/30/2019 04:46 PM] |
Filing 12 Entry of appearance for Jeffrey J. Oelke as principal counsel for Appellants Altergon, S.A., IBSA Institut Biochimique, S.A. and IBSA Pharma Inc.. Service: 09/30/2019 by email. [639190] [19-2400] [Jeffrey Oelke] [Entered: 09/30/2019 04:40 PM] |
Filing 11 Certificate of Interest for Appellants Altergon, S.A., IBSA Institut Biochimique, S.A. and IBSA Pharma Inc.. Service: 09/30/2019 by email. [639184] [19-2400] [Jeffrey Oelke] [Entered: 09/30/2019 04:31 PM] |
Filing 10 Docketing Statement for the Appellants Altergon, S.A., IBSA Institut Biochimique, S.A. and IBSA Pharma Inc.. Service: 09/30/2019 by email. [639176] [19-2400] [Jeffrey Oelke] [Entered: 09/30/2019 04:23 PM] |
Filing 9 Entry of appearance for Deirdre M. Wells as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 09/30/2019 by email. [639082] [19-2400] [Kristina Caggiano Kelly] [Entered: 09/30/2019 01:24 PM] |
Filing 8 Entry of appearance for Kristina Caggiano Kelly as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 09/30/2019 by email. [639080] [19-2400] [Kristina Caggiano Kelly] [Entered: 09/30/2019 01:23 PM] |
Filing 7 Entry of appearance for Michael E. Joffre as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 09/30/2019 by email. [639078] [19-2400] [Michael Joffre] [Entered: 09/30/2019 01:21 PM] |
Filing 6 Docketing Statement for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 09/30/2019 by email. [639077] [19-2400] [John Rozendaal] [Entered: 09/30/2019 01:19 PM] |
Filing 5 Certificate of Interest for Appellee Teva Pharmaceuticals USA, Inc.. Service: 09/30/2019 by email. [639075] [19-2400] [John Rozendaal] [Entered: 09/30/2019 01:18 PM] |
Filing 4 Entry of appearance for John Christopher Rozendaal as principal counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 09/30/2019 by email. [639073] [19-2400] [John Rozendaal] [Entered: 09/30/2019 01:17 PM] |
Filing 3 NOTICE OF NON-COMPLIANCE: The submission of Appellants Altergon, S.A., IBSA Institut Biochimique, S.A., and IBSA Pharma Inc., Transcript Purchase Order Form [ # 2 ], is not in compliance with the rules of this court (see attached). Compliant document is due on 10/01/2019. Service as of this date by the Clerk of Court. [637827] [JAL] [Entered: 09/24/2019 02:29 PM] |
Filing 2 Transcript Purchase Order Form for the Appellants Altergon, S.A., IBSA Institut Biochimique, S.A. and IBSA Pharma Inc. indicating that a transcript is already on file. Service: 09/23/2019 by email. [637590] [19-2400] This document is non-compliant. See Doc No.[ # 3 ] [Laura Moran] [Entered: 09/23/2019 05:00 PM] |
Filing 1 Appeal docketed. Received: 09/10/2019. [635668] Entry of Appearance due 09/30/2019. Certificate of Interest is due on 09/30/2019. Docketing Statement due 09/30/2019. Appellants' brief is due 11/15/2019. [TAM] [Entered: 09/16/2019 11:01 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.